Guardion Health Sciences Inc (GHSI)
8.13
-0.01
(-0.12%)
USD |
NASDAQ |
May 03, 15:38
Guardion Health Sciences Price to Book Value: 1.282 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 1.283 |
| May 01, 2024 | 1.261 |
| April 30, 2024 | 1.245 |
| April 29, 2024 | 1.249 |
| April 26, 2024 | 1.245 |
| April 25, 2024 | 1.285 |
| April 24, 2024 | 1.258 |
| April 23, 2024 | 1.305 |
| April 22, 2024 | 1.261 |
| April 19, 2024 | 1.260 |
| April 18, 2024 | 1.269 |
| April 17, 2024 | 1.272 |
| April 16, 2024 | 1.238 |
| April 15, 2024 | 1.244 |
| April 12, 2024 | 1.245 |
| April 11, 2024 | 1.277 |
| April 10, 2024 | 1.246 |
| April 09, 2024 | 1.220 |
| April 08, 2024 | 1.403 |
| April 05, 2024 | 1.430 |
| April 04, 2024 | 1.383 |
| April 03, 2024 | 1.435 |
| April 02, 2024 | 1.427 |
| April 01, 2024 | 1.430 |
| March 28, 2024 | 1.423 |
| Date | Value |
|---|---|
| March 27, 2024 | 1.420 |
| March 26, 2024 | 1.422 |
| March 25, 2024 | 1.420 |
| March 22, 2024 | 1.433 |
| March 21, 2024 | 1.430 |
| March 20, 2024 | 1.420 |
| March 19, 2024 | 1.419 |
| March 18, 2024 | 1.406 |
| March 15, 2024 | 1.280 |
| March 14, 2024 | 1.277 |
| March 13, 2024 | 1.251 |
| March 12, 2024 | 1.240 |
| March 11, 2024 | 1.240 |
| March 08, 2024 | 1.244 |
| March 07, 2024 | 1.259 |
| March 06, 2024 | 1.241 |
| March 05, 2024 | 1.244 |
| March 04, 2024 | 1.274 |
| March 01, 2024 | 1.277 |
| February 29, 2024 | 1.306 |
| February 28, 2024 | 1.262 |
| February 27, 2024 | 1.304 |
| February 26, 2024 | 1.298 |
| February 23, 2024 | 1.327 |
| February 22, 2024 | 1.316 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2124
Minimum
Feb 22 2022
23.36
Maximum
Jun 04 2019
2.387
Average
1.159
Median
Oct 11 2023
Price to Book Value Benchmarks
| Madrigal Pharmaceuticals Inc | 11.24 |
| Viking Therapeutics Inc | 9.141 |
| Akero Therapeutics Inc | 2.552 |
| 89bio Inc | 1.637 |
| Ensysce Biosciences Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 73.91 |
| PS Ratio | 0.8416 |
| Price | 8.13 |
| Earnings Yield | 1.35% |
| Market Cap | 10.44M |